The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.

The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell ...

Quell and AstraZeneca entered a collaboration, exclusive option and license agreement in June 2023 to develop, manufacture and commercialize autologous, engineered Treg cell therapies for two ...

Plug Power Inc. (NASDAQ: PLUG) is a green energy company with an ambitious vision for a hydrogen-powered future. The company ...

Compared with a year ago, Silver Ring Value Partners' portfolio is more undervalued and better balanced. Click here to read ...

The pandemic turned many people against public-health experts – creating the opening that has resulted in Robert F. Kennedy ...

China's National Oil and Gas pipeline network group has announced the completion of the China-Russia east-route natural gas ...

Johnston, a research fellow at Melbourne’s Monash University, does not agree. Death is not inevitable and it should be ...

Liverpool's ongoing search for a long-term Mohamed Salah replacement points towards the signing of another Egyptian, Omar ...

According to figures from Mr. Marchick, the average tenure for a cabinet secretary in Mr. Trump’s first term other than ...

Dr Athman says that among the people with cancer in Kenya, prostate cancer lies third, in terms of the number of patients.

Analyst Predicts Another Blow To Households Domestic energy bills for typical households are forecast to rise by 1% from January 2025, writ ...